Patron Exim Ltd
Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Trading - Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtors Turnover Ratio Times ・Standalone data |
|
||
| Number of Permanent Employees Numbers ・Standalone data |
|||
| Product Portfolio (APIs, Excipients & Chemicals) Numbers ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Statement Of Deviation & Variation For The Half Year Ended March 31 2026
29 May - Statement of deviation/variation for Rs.16.68 crore issue filed for half year ended 31 March 2026.
-
Audited Standalone Financial Results For The Half Year And Financial Year Ended March 31, 2026
29 May - Board approved FY26 audited results on May 29, 2026; auditors issued qualified opinion citing loans, taxes and compliance issues.
-
Board Meeting Outcome for Declaration Of Audited Standalone Financial Results For The Half Year And Financial Year Ended March 31, 2026
29 May - Patron Exim approved FY26 audited results; net loss Rs108.96 lakh; auditors issued qualified opinion over tax and loan issues.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Independent Director Sumitkumar Patel resigns effective June 1, 2026, citing other professional commitments.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
29 May - Mr. Sumitkumar Patel resigns as Independent Director effective June 1, 2026.
Business Overview:[1]
PEL used to do trading of timber, cement sheets and other ancillary business, and also in surgical & non-surgical articles. Currently, company is an ISO 9001:2015, ISO 45001:2018, WHO-GMP, etc. certified trader and distributor of wide range of pharmaceutical raw material like Active Pharmaceutical Ingredients, Industrial, excipient, and solvents